Review



transcript 4 ilt4  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Santa Cruz Biotechnology transcript 4 ilt4
    Transcript 4 Ilt4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcript+4+ilt4/ILT-4+siRNA/pmc10042695-25-13-20
    Average 91 stars, based on 1 article reviews
    transcript 4 ilt4 - by Bioz Stars, 2026-09
    91/100 stars

    Images

    Related Articles

    other:

    Article Title: ANGPTL2 promotes VEGF-A synthesis in human lung cancer and facilitates lymphangiogenesis
    Article Snippet: Small interfering RNAs (siRNAs) against integrin α5 (sc-29372) and β1(sc-35674), and immunoglobulin (Ig)-like transcript 4 (ILT4) (sc-45200) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).



    Similar Products

    91
    Santa Cruz Biotechnology transcript 4 ilt4
    Transcript 4 Ilt4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcript+4+ilt4/ILT-4+siRNA/pmc10042695-25-13-20
    Average 91 stars, based on 1 article reviews
    transcript 4 ilt4 - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology transcript 4 ilt4 42d1
    Interferon (IFN)-γ in combination with the FAST-dendritic cell (DC) protocol generates phenotypically tolerogenic DC. Monocytes were isolated from peripheral blood and cultured without (UT-DC) or with IFN-γ (IFN-γ-DC) in the presence of interleukin (IL)-4 and granulocyte–macrophage colony-stimulating factor (GM-CSF) for 24 h. DC were then either matured with tumour necrosis factor (TNF)-α (10 ng/ml) and prostaglandin E2 (PGE2) (1 µM) for another 24 h (a: plus TNF-α and PGE2, representative of six independent experiments) or were cultured for another 24 h in the absence (b: minus TNF-α and PGE2, representative of three independent experiments. Fluorescence activated cell sorter (FACS) analysis was used to determine phenotypic markers. The following co-stimulatory and linage markers were examined: CD83, CD80, CD86, immunoglobulin (Ig)-like transcript 4 <t>(ILT4),</t> CD11c, DC-SIGN, CD14, human leucocyte antigen D-related (HLA-DR). Line indicates the isotype control and solid histogram shows the tested monoclonal antibody. Negative gate was set to <0·5%.
    Transcript 4 Ilt4 42d1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcript+4+ilt4/ILT-4+Antibody/pmc03374277-54-44-48
    Average 91 stars, based on 1 article reviews
    transcript 4 ilt4 42d1 - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    90
    R&D Systems fitc-labeled anti-ig-like transcript 4 (ilt4
    Interferon (IFN)-γ in combination with the FAST-dendritic cell (DC) protocol generates phenotypically tolerogenic DC. Monocytes were isolated from peripheral blood and cultured without (UT-DC) or with IFN-γ (IFN-γ-DC) in the presence of interleukin (IL)-4 and granulocyte–macrophage colony-stimulating factor (GM-CSF) for 24 h. DC were then either matured with tumour necrosis factor (TNF)-α (10 ng/ml) and prostaglandin E2 (PGE2) (1 µM) for another 24 h (a: plus TNF-α and PGE2, representative of six independent experiments) or were cultured for another 24 h in the absence (b: minus TNF-α and PGE2, representative of three independent experiments. Fluorescence activated cell sorter (FACS) analysis was used to determine phenotypic markers. The following co-stimulatory and linage markers were examined: CD83, CD80, CD86, immunoglobulin (Ig)-like transcript 4 <t>(ILT4),</t> CD11c, DC-SIGN, CD14, human leucocyte antigen D-related (HLA-DR). Line indicates the isotype control and solid histogram shows the tested monoclonal antibody. Negative gate was set to <0·5%.
    Fitc Labeled Anti Ig Like Transcript 4 (Ilt4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcript+4+ilt4/antibody+against+ilt4/pmc03252843-64-30-38
    Average 90 stars, based on 1 article reviews
    fitc-labeled anti-ig-like transcript 4 (ilt4 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Interferon (IFN)-γ in combination with the FAST-dendritic cell (DC) protocol generates phenotypically tolerogenic DC. Monocytes were isolated from peripheral blood and cultured without (UT-DC) or with IFN-γ (IFN-γ-DC) in the presence of interleukin (IL)-4 and granulocyte–macrophage colony-stimulating factor (GM-CSF) for 24 h. DC were then either matured with tumour necrosis factor (TNF)-α (10 ng/ml) and prostaglandin E2 (PGE2) (1 µM) for another 24 h (a: plus TNF-α and PGE2, representative of six independent experiments) or were cultured for another 24 h in the absence (b: minus TNF-α and PGE2, representative of three independent experiments. Fluorescence activated cell sorter (FACS) analysis was used to determine phenotypic markers. The following co-stimulatory and linage markers were examined: CD83, CD80, CD86, immunoglobulin (Ig)-like transcript 4 (ILT4), CD11c, DC-SIGN, CD14, human leucocyte antigen D-related (HLA-DR). Line indicates the isotype control and solid histogram shows the tested monoclonal antibody. Negative gate was set to <0·5%.

    Journal: Clinical and Experimental Immunology

    Article Title: Early exposure of interferon-? inhibits signal transducer and activator of transcription-6 signalling and nuclear factor ?B activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells

    doi: 10.1111/j.1365-2249.2011.04537.x

    Figure Lengend Snippet: Interferon (IFN)-γ in combination with the FAST-dendritic cell (DC) protocol generates phenotypically tolerogenic DC. Monocytes were isolated from peripheral blood and cultured without (UT-DC) or with IFN-γ (IFN-γ-DC) in the presence of interleukin (IL)-4 and granulocyte–macrophage colony-stimulating factor (GM-CSF) for 24 h. DC were then either matured with tumour necrosis factor (TNF)-α (10 ng/ml) and prostaglandin E2 (PGE2) (1 µM) for another 24 h (a: plus TNF-α and PGE2, representative of six independent experiments) or were cultured for another 24 h in the absence (b: minus TNF-α and PGE2, representative of three independent experiments. Fluorescence activated cell sorter (FACS) analysis was used to determine phenotypic markers. The following co-stimulatory and linage markers were examined: CD83, CD80, CD86, immunoglobulin (Ig)-like transcript 4 (ILT4), CD11c, DC-SIGN, CD14, human leucocyte antigen D-related (HLA-DR). Line indicates the isotype control and solid histogram shows the tested monoclonal antibody. Negative gate was set to <0·5%.

    Article Snippet: Antibodies The phenotypic profile of DC was defined using the following directly conjugated monoclonal antibodies (mAb): anti-CD83-fluorescein isothiocyanate (FITC) (HB15e), anti-CD86-FITC (FUN1), anti-CD80-FITC (L307·4), anti-DC-SIGN-FITC (DCN46), anti-human leucocyte antigen D-related (HLA-DR)-phycoerythrin-cyanin-5 (PE-Cy5) (G46-6) (BD Bioscience, San Jose, CA, USA) and rat anti-human immunoglobulin (Ig)-like transcript 4 (ILT4) (42D1) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used as a primary mAb and FITC-conjugated anti-rat IgG was used for detection.

    Techniques: Isolation, Cell Culture, Fluorescence, Control